Wednesday, December 16, 2009

2:30-5:30pm 
Registration -  Ocean Lanai Terrace

5:45–6:55pm
Welcome Reception

Evening Plenary Session
           
7:00-7:05pm   
Introduction: Robert Langer and Yasuhiko Tabata

Discussion Leader: Mike Sefton

7:05-7:45pm
John Santini
President and Chief Executive Officer, MicroCHIPS, Inc.
Addressing drug delivery challenges with intelligent implantable devices

7:45-8:25pm
Yasuyoshi Watanabe
Director, RIKEN Center for Molecular Imaging Science
Drug delivery systems and PK/PD studies with molecular imaging

8:25-8:55pm - Refreshment Break

8:55-9:35pm
Francis Szoka
Professor of Biopharmaceutical Sciences, University of California, San Francisco
Back to the future: New lipids to solve an old problem:  Drug and nucleic acid delivery

9:35-10:15pm
Joseph DeSimone
Chancellor’s Eminent Professor of Chemistry; Kenan Jr. Distinguished Professor of Chemical Engineering, University of North Carolina-Chapel Hill and North Carolina State University
Translating the precision of microelectronics to the production of highly uniform shape-specific carriers for vaccines, biologics and small molecule drugs

Thursday, December 17, 2009

7:00 - 8:00am
Registration, Ocean Lanai Terrace                       

Morning Plenary Session
           
Discussion Leader: Allan Hoffman

8:30-9:10am  
Kazunori Kataoka
Professor, University of Tokyo
Block copolymer micelles and vesicles as nanocarriers for gene and drug delivery

9:10-9:50am
Henry Brem
Director of Neurosurgery and Professor, Johns Hopkins School of Medicine
New approaches to treating brain tumors

9:50-10:30am
Shigeru Kawakami
Assistant Professor, Kyoto University
Development and evaluation of organ-press mediated in vivo gene transfection methods of plamid DNA and siRNA

10:30-11:00am – Refreshment Break

11:00-11:40am
Rodney Pearlman
Twenty years of protein drug delivery:  The good, the bad, the ugly

11:40am-12:20pm
Christine Bunt
Chief Operating Officer and Founder, TARIS Biomedical
Drug-device convergence for diseases of the bladder

Afternoon Unscheduled

Evening Plenary Session      

Discussion Leader: Tsuneji Nagai

7:00-7:40pm
Victor Kotelianski
Senior Vice President of Research, Alnylam Pharmaceuticals
Progress in the development of delivery systems for siRNA

7:40-8:20pm
Juichi Ito
Professor and Chairman of the Department of Otolaryngology-Head and Neck Surgery, Kyoto University
New drug delivery systems for inner ear diseases

8:20-8:50pm - Refreshment Break

8:50-9:30pm
Sung Wan Kim
Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry, University of Utah
Newly designed polymers for the delivery of siRNA

9:30-10:10pm
Lloyd Johnston
Vice President, Pharmaceutical Research and Development, Selecta Biosciences, Inc.
Multifunctional immunomodulatory nanoparticles for therapeutic vaccines

Friday, December 18, 2009

Morning Plenary Session

Discussion Leader: Yasuhiko Tabata

8:30-9:10am
Yoshinobu Baba
Professor, Nagoya University
Nanotechnology for cancer stem cell diagnosis and in vivo stem cell imaging for tissue engineering

9:10-9:50am
Gerald Bernstein
Vice President, Medical Affairs, Director, Generex Biotechnology Corp.
The more we know the more complex it gets: Diabetes, a moving target

9:50-10:30am
Yasufumi Kaneda
Professor, Osaka University
Novel anti-cancer strategies using HVJ (Sendai virus) envelope

10:30-11:00am – Refreshment Break

11:00-11:40am
Nicholas Peppas
Fletcher Stuckey Pratt Chair in Engineering, University of Texas – Austin
Recognition and delivery:  The next generation of medical microdevices

11:40am-12:20pm
Kenji Hyodo
Scientist, Eisai Co., Ltd.
Inhibition of cancer metastasis by targeted delivery of antioxidant enzymes

Afternoon Unscheduled

Evening Session – Poster Session 1

Discussion Leader: Michael J. Cima

7:30pm – 9:30pm
Oral Presentation of Posters - Selected from Poster Session #1 
                       
           
8:30pm – Refreshment Break

Session ends at approximately 10:00 pm

Saturday, December 19, 2009

Morning Plenary Session

Discussion Leader: Larry Sternson

8:30-9:10am
Koji Hanai
Scientist, Dainippon Sumitomo Pharma Co., Ltd.
Progress of atelocollagen-mediated drug delivery systems for nucleic acid medicines

9:10-9:50am
Jeff Hrkach
Vice President, Pharmaceutical Sciences, BIND Biosciences, Inc
The development of BIND targeted nanotherapeutics

9:50-10:30am
Eric Tomlinson
President and Chief Executive Officer, Altea Therapeutics Corp.
The efficient transdermal delivery of biotherapeutics from a conventional skin patch

10:30-11:00am - Refreshment Break

11:00-11:40am
Hideyuki Okano
Professor and Chairman, Department of Physiology, Keio University
Strategies toward CNS-Regeneration using IPS cell technology

11:40am-12:20pm
Oliver Fetzer
President and Chief Executive Officer, Cerulean Pharma, Inc.
Advances in the development of nanopharmaceuticals

Afternoon Unscheduled

Evening Plenary Session

Discussion Leader: Daniel S. Kohane

7:00pm-7:40pm
John Patton
Founder and Chief Scientific Officer, Dance Pharma
Inhaled medicines for systemic action

7:40-8:20pm
Takayuki Yoshida
Scientist, Astellas Pharma, Inc.
pH-sensitive PEG release from nanoparticles for gene delivery

8:20-8:50pm - Refreshment Break

8:50-9:30pm
Shaoyi Jiang
Professor, University of Washington and SAB Co-Chairman
Christopher Loose
Chief Technology Officer, Semprus BioSciences
Polymers for reducing medical device complications and enhancing drug delivery

9:30-10:10pm
Joseph Kim
President and Chief Executive Officer, Inovio Biomedical Corporation        
Electric fields for vaccine delivery:  How in vivo electroporation could fulfill the promise of DNA vaccines

Sunday, December 20, 2009

Morning Plenary Session

Discussion Leader: Amir Nashat
           
8:30-9:10am
Howie Rosen
Lecturer, Department of Chemical Engineering, Stanford University
Ouch! The role of drug delivery in pain management

9:10-9:50am
Yuichi Sugiyama
Professor, University of Tokyo
Evolutional drug development with the use of microdosing clinical trial:  Quantitative prediction of ADME with PET imaging

9:50-10:20am
Maria Palasis
Executive Vice President, Research and Development, Arsenal Medical
Combination products in drug delivery:  Enabling site specific therapy with medical devices

10:20am - 11:00am – Refreshment Break

11:00-11:40am
Ronald E. Peeples
Vice President, Pharmaceutical R&D and Supplies, Pfizer BioTherapeutics
Development of advanced drug delivery products for biotherapeutics

Afternoon Unscheduled

Evening Session – Poster Session 2

Discussion Leader: Daniel G. Anderson         

7:30pm
Oral Presentation Of Posters - Selected From Poster Session #2       
                                   
8:30pm - Refreshment Break

Session Ends at Approximately 10:00 p.m.

Thank you for participating - we hope to see you again at the 11th Symposium in 2011.